Nature Reviews Drug Discovery 17, 588–606 (2018)
A sentence mentioning the authors of reference 122 has been amended to include both corresponding authors.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/nrd.2018.97
Rights and permissions
About this article
Cite this article
Mangan, M., Olhava, E., Roush, W. et al. Erratum: Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17, 688 (2018). https://doi.org/10.1038/nrd.2018.149
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.149
This article is cited by
-
Chronic osteomyelitis risk is associated with NLRP3 gene rs10754558 polymorphism in a Chinese Han Population
BMC Medical Genomics (2024)
-
Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome
Chinese Medicine (2024)
-
Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis
Chinese Medicine (2024)
-
Aiouea padiformis extract exhibits anti-inflammatory effects by inhibiting the ATPase activity of NLRP3
Scientific Reports (2024)
-
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment
Cancer Gene Therapy (2024)
